Ticagrelor enhances the cardioprotective effects of ischemic preconditioning in stable patients undergoing percutaneous coronary intervention: the TAPER-S randomized study.
D'Amario D, Galli M, Restivo A, Canonico F, Vergallo R, Migliaro S, Trani C, Burzotta F, Aurigemma C, Laborante R, Romagnoli E, Francese F, Ceccarelli I, Borovac JA, Angiolillo DJ, Tavazzi B, Leone AM, Crea F, Patti G, Porto I.
D'Amario D, et al. Among authors: laborante r.
Eur Heart J Cardiovasc Pharmacother. 2024 May 4;10(3):190-200. doi: 10.1093/ehjcvp/pvad092.
Eur Heart J Cardiovasc Pharmacother. 2024.
PMID: 38006237
Clinical Trial.